An association of CSF apolipoprotein E glycosylation and amyloid-beta 42 in individuals who carry the APOE4 allele. Meuret CJ, Hu Y, Smadi S, Bantugan MA, Xian H, Martinez AE, Krauss RM, Ma QL, Nedelkov D, Yassine HN. Alzheimers Res Ther. 2023 May 23;15(1):96. doi: 10.1186/s13195-023-01239-0. PMID: 37221560

Effect of the ABCA1 agonist CS-6253 on amyloid-β and lipoprotein metabolism in cynomolgus monkeys. Noveir SD, Kerman BE, Xian H, Meuret C, Smadi S, Martinez AE, Johansson J, Zetterberg H, Parks BA, Kuklenyik Z, Mack WJ, Johansson JO, Yassine HN. Alzheimers Res Ther. 2022 Jun 24;14(1):87. doi: 10.1186/s13195-022-01028-1.

The small HDL particle hypothesis of Alzheimer’s disease. Martinez AE, Weissberger G, Kuklenyik Z, He X, Meuret C, Parekh T, Rees JC, Parks BA, Gardner MS, King SM, Collier TS, Harrington MG, Sweeney MD, Wang X, Zlokovic BV, Joe E, Nation DA, Schneider LS, Chui HC, Barr JR, Han SD, Krauss RM, Yassine HN. Alzheimers Dement. 2022 Apr 13. doi: 10.1002/alz.12649. Online ahead of print.

Understanding the Exchange of Systemic HDL Particles Into the Brain and Vascular Cells Has Diagnostic and Therapeutic Implications for Neurodegenerative Diseases. Van Valkenburgh J, Meuret C, Martinez AE, Kodancha V, Solomon V, Chen K, Yassine HN. Front Physiol. 2021 Sep 6;12:700847. doi: 10.3389/fphys.2021.700847. eCollection 2021.

Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer’s disease. Hu Y, Meuret C, Martinez A, Yassine HN, Nedelkov D. J Lipid Res. 2021;62:100014. doi: 10.1194/jlr.RA120000919. Epub 2020 Dec 18.

Simple and Fast Assay for Apolipoprotein E Phenotyping and Glycotyping: Discovering Isoform-Specific Glycosylation in Plasma and Cerebrospinal Fluid.  Hu Y, Meuret C, Go S, Yassine HN, Nedelkov D. J Alzheimers Dis. 2020;76(3):883-893. doi: 10.3233/JAD-200203.